{"groups":[{"description":"Pomalidomide: Only enough CC-4047 for 1 cycle of therapy may be provided to the patient each cycle. Participants will receive CC-4047 4 mg/day for 21 days, every 28 days. Treatment will continue until disease recurrence or untoward toxicity.","id":"FG000","title":"Pomalidomide"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"71"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"71"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}